Medical Weight Loss · GLP-1
Medical weight loss, backed by science.
Prescribed by licensed providers. GLP-1 medications studied for appetite regulation and weight management. Bilingual care. No insurance needed. From $199/month, all-inclusive.
- Licensed clinical review
- Semaglutide or tirzepatide
- From $199/mo all-inclusive
- Bilingual support
- Cancel anytime
What is GLP-1 weight loss?
Science-backed weight loss that actually works.
GLP-1 receptor agonists (like semaglutide and tirzepatide) mimic a natural hormone that regulates appetite, blood sugar, and metabolism. Originally developed for type 2 diabetes, these medications have shown remarkable results for weight loss in clinical trials.
REMEVi offers compounded semaglutide and compounded tirzepatide, prepared by state-licensed US compounding pharmacies and prescribed by licensed US providers. Compounded medications are non-FDA-approved preparations and are not generic versions of Ozempic®, Wegovy®, Mounjaro®, or Zepbound®.
In clinical trials of the FDA-approved branded products, patients lost an average of 14.9% of their body weight on semaglutide and up to 22.5% on tirzepatide over 68 weeks. Those trial outcomes relate to the FDA-approved finished products and not to compounded preparations.
How GLP-1 works
Appetite suppression
Signals your brain to feel full faster and eat less.
Slowed digestion
Food moves through your digestive system more slowly.
Improved blood sugar
Stabilizes glucose levels and reduces cravings.
Weight loss
Consistent, sustained weight loss over time.
Your options
Semaglutide vs. tirzepatide
Both are GLP-1 medications with proven weight loss results. Choose based on preference and provider recommendation.
Semaglutide
- Brand names
- Ozempic, Wegovy
- Mechanism
- GLP-1 receptor agonist
- Average weight loss
- 14.9% body weight
- Frequency
- Once weekly injection
- Dosage timeline
- 0.25mg → 2.0mg over 20 weeks
- Best for
- Moderate to significant weight loss
At REMEVi
From $199/mo
All-inclusive, 52-week plan
Tirzepatide
- Brand names
- Mounjaro, Zepbound
- Mechanism
- GLP-1 + GIP receptor agonist
- Average weight loss
- 22.5% body weight
- Frequency
- Once weekly injection
- Dosage timeline
- 2.5mg → 15mg over 16 weeks
- Best for
- Maximum weight loss potential
At REMEVi
From $269/mo
All-inclusive, more powerful
Eligibility
Who qualifies for GLP-1 weight loss?
You may qualify if you:
- Are 18 years or older
- Have a BMI ≥ 27 (or ≥ 25 with weight-related condition)
- Do not have type 1 diabetes
- Have no personal/family history of MTC or MEN2
- Are not pregnant or breastfeeding
Consult your licensed provider if you have:
- Pancreatitis history
- Severe gastrointestinal disease
- Kidney or liver disease
- Eating disorder history
- Currently taking insulin or sulfonylureas
Every case is evaluated individually by a licensed provider. Complete an intake to receive a personalized evaluation.
All-inclusive
Everything in your REMEVi plan
One transparent price. No hidden fees, no surprise charges.
Licensed provider eval
Board-certified US clinical reviews your case within 24 hours.
GLP-1 medication
Your choice of semaglutide or tirzepatide from FDA-regulated pharmacy.
Free monthly shipping
Discreet packaging. Shipped free every single month.
Bilingual care team
Spanish and English support with 2-hour response SLA.
Dose management
Licensed provider adjusts your dose monthly based on your progress.
Patient portal
Track progress, message your team, manage subscription online.
What to expect
Medical weight loss timeline
Realistic milestones and what typically happens at each stage.
Week 2–4
Appetite reduction
Noticeable decrease in hunger. Easier to eat smaller portions. Some mild nausea as your body adjusts (resolves quickly).
Week 4–8
Early weight loss
First pounds drop. Clothes fit differently. Energy may fluctuate as your body adapts to new eating patterns.
Month 3–4
Accelerated loss
Weight loss becomes consistent and visible. Confidence builds. Most side effects resolved. Craving control improves significantly.
Month 6+
Sustained results
10–22% body weight reduction (depending on medication). Maintenance dose achieved. Lifestyle habits solidified. Long-term results possible with continued use.
Free tool
See how much weight you could lose
Enter your current weight to see projected results with semaglutide and tirzepatide.
Projected Weight Loss
Semaglutide
Average total loss: 14.9%
Tirzepatide
Average total loss: 22.5%
Results based on STEP 1 and SURMOUNT-1 clinical trials. Individual results vary. Medication prescribed by licensed providers.
FAQ
Medical weight loss questions answered
GLP-1 medications work on the hormonal and neurological level to reduce appetite and increase satiety. Studies show patients lose 2-3x more weight with GLP-1 than with diet and exercise alone. Medical supervision also ensures your weight loss is safe and sustainable.
The most common side effects are nausea, vomiting, diarrhea, and constipation — especially when starting or increasing the dose. These typically resolve within a few weeks. Serious side effects are rare. Your licensed provider will discuss all risks before you start.
GLP-1 medications can be used long-term under clinical supervision. Many patients maintain a lower maintenance dose after reaching their goal. Some may eventually transition to lifestyle management alone. Your REMEVi licensed provider will work with you to create a sustainable plan.
Absolutely. In fact, exercise combined with GLP-1 medication produces better results than either alone. Your reduced appetite and increased energy make exercise easier. Discuss your exercise routine with your REMEVi care team.
No. REMEVi is available without insurance. Our all-inclusive pricing ($199–$309/mo depending on medication choice and plan length) covers everything — clinical review, medication, shipping, and care coordination.
REMEVi licensed providers monitor your progress monthly. If one medication isn't working, your licensed provider can switch you to the other option (semaglutide to tirzepatide or vice versa). Most patients see results, but we're committed to finding what works for you.
Pricing
Transparent pricing. Pick your plan.
All plans include clinical review, medication, shipping, and bilingual support.
Semaglutide
From $199
per month, all-inclusive (52-week plan)
Compounded semaglutide prescribed by licensed US providers
Get startedTirzepatide
From $269
per month, all-inclusive (52-week plan)
Compounded tirzepatide — dual GLP-1/GIP receptor agonist
Get startedOral Semaglutide
From $249
per month, all-inclusive (52-week plan)
Daily oral compounded semaglutide — needle-free option
Get startedReady to start your weight loss journey?
Complete a 5-minute intake form. A licensed clinical reviews within 24 hours.
Start free consult — from $199/mo